Moreover, modulation of the SIRT1 enzyme seems to be responsible for the pharmacological effects of resveratrol in non-vascular cells, such as tenocytes [61], chondrocytes [62], fibroblasts [63], and cancer cells [64]. Here, SIRT1 is linked to cancer.